Industry Perspectives - Design & Development

  1. Bioresorbable Polymers: The Next Generation In Stent Technology

    Next-generation stent technology is and will be bio-absorbable or bioresorbable. To gain a richer understanding of the current trends, I sat down with Craig Thompson, MD, who is SVP/CMO of Boston Scientific’s Interventional Cardiology. Dr. Thompson also provided insight behind the SYNERGY Coronary Stent's development.

  2. Innovative vs. Intuitive: 5 Ways To Ensure Novelty Doesn’t Compromise Usability

    Innovation can often upset the apple cart, especially in cases where new and unfamiliar technologies are utilized to enable new functionality. This less-than-optimal user experience can hurt the product’s adoption and lead to high rates of abandonment. Here are five suggestions to ensure that new designs lead to safe, effective, and desirable outcomes.

  3. Boston Scientific’s Plan To Create Modular Pacing — A Chat With Dr. Ken Stein, SVP/CMO, Cardiac Rhythm Management

    Med Device Online recently interviewed Dr. Ken Stein, SVP and chief medical officer at Boston Scientific CRM. Dr. Stein discussed his company’s yet-to-be-named, leadless micro pacer, where the device stands in development, and how Boston Scientific plans to combine its new pacing technology with its subcutaneous implantable defibrillator (S-ICD) to create a flexible modular system.

  4. 3 Strategies For Expanding Global Access To Your Medical Device: A Radiotherapy Case Study

    Fourteen million people worldwide were diagnosed with cancer in 2012, and experts predict 22 million people will receive a cancer diagnosis in 2030. Here, we examine how the processes used to broaden access to radiotherapy can readily be adapted by other members of the medical device community to improve the treatment of cancer patients and to create additional market value.

  5. Insiders’ Guide To Winning In the Drug Delivery Device Market — Part 5: The Internet of Things

    To learn more about how the IoT will impact medtech as a whole, and drug delivery in particular, I interviewed Stephen Wilcox, principal and founder of Design Science, Inc. We discussed his thoughts on trends in the drug delivery device market, how he sees the evolution of the IoT transforming healthcare technology, and what implications the technology holds for device developers.

  6. How To Win Support (Internal & External) For Your Medical Device

    At many med device companies, lots of new and potentially promising innovations may be on the table for funding consideration at any given time. This article explains how to make your early-stage business case based on consideration of what should maximize revenue, what is technically feasible, and what customers want to — and will — buy.

  7. Will Funding Woes Doom The Next Generation Of Medtech Innovators?

    With two full years of information now available since the Affordable Care Act’s passage, a disconcerting pattern has emerged affecting small companies and startups — the primary sources of new innovation, and the life blood of medtech. Will industry and market disruption created by the ACA lead to unintended, long-term restrictions for medtech innovation?

  8. Are Design Control Myths Holding Back Your Product Development?

    “Make sure you document all those design controls,” said maybe no boss ever. You’re trying to meet aggressive deadlines, getting a new prototype ready for testing, or preparing for your animal study. But design controls exist to help your efforts, not to hinder them. 

  9. Keeping It Simple: One Startup’s Plan To Upend The Epinephrine Delivery Market

    What does it take to overcome the challenges in a market with a dominant, entrenched leader? Med Device Online recently had a chance to discuss the topic with Chris Stepanian, CEO of medtech startup Windgap Medical. Stepanian shared his views on those issues and detailed his company’s plan to evolve auto injector device technology.

  10. 3 Key Healthcare Adoption Drivers: How They (Should) Shape Product Development

    Introducing a new product into a hospital or other healthcare system is an increasingly arduous task. Compelling, user-centered design alone doesn’t ensure a product’s successful introduction or adoption. Striking the right balance to ensure key priorities are met — across both the complex healthcare ecosystem and the larger audience of device stakeholders — could be the difference between market failure and commercial success.